Neuropeptides and the control of energy homeostasis.
Woods
S C
SC
Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
Rushing
P A
PA
Seeley
R J
RJ
D000273:Adipose Tissue / Q000502:physiology; D000682:Amyloid / Q000502:physiology; D000818:Animals; D001835:Body Weight / Q000502:physiology; D004361:Drug Tolerance; D002149:Energy Intake / Q000502:physiology*; D004734:Energy Metabolism / Q000502:physiology*; D006706:Homeostasis; D006801:Humans; D007031:Hypothalamus / Q000502:physiology; D007328:Insulin / Q000502:physiology; D058228:Islet Amyloid Polypeptide; D020738:Leptin / Q000502:physiology; D009479:Neuropeptides / Q000008:administration & dosage / Q000502:physiology*; D009765:Obesity / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*
D000682:Amyloid; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D020738:Leptin; D009479:Neuropeptides